ArticleTrials2023

Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority randomized controlled trial.

Tienan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.